A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

NCT07196722 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

1092

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Icotrokinra
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC